Emilio J. Laserna‐Mendieta

Author

Also Known As

E. J. Laserna-Mendieta, E. J. Laserna‐Mendieta, E.J. Laserna-Mendieta, Emilio J Laserna-Mendieta, Emilio J Laserna‐Mendieta, Emilio J. Laserna-Mendieta, Emilio J. Laserna‐Mendieta, Emilio José Laserna Mendieta, Emilio José Laserna-Mendieta, Emilio José Laserna‐Mendieta

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Hospital General de Tomelloso Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Hospital Universitario de La Princesa University College Cork APC Microbiome Institute

About

Emilio J. Laserna‐Mendieta is an author at Hospital General de Tomelloso specializing in medicine, immunology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	267
2	Allergy	3	3	147
3	Public Health	1	1	14
4	Biostatistics	1	1	14
5	Epidemiology	1	1	14

Emilio J. Laserna‐Mendieta

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease Feargal J. Ryan, Anna M. Ahern, Rachel S. Fitzgerald, Nature Communications	2020	271
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study Adam G. Clooney, Julia Eckenberger, Emilio J. Laserna‐Mendieta, Gut	2020	237
A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors Adam G. Clooney, Çharles N. Bernstein, William D. Leslie, Alimentary Pharmacology & Therapeutics	2016	157
Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry Emilio J. Laserna‐Mendieta, Sergio Casabona, Danila Guagnozzi, Alimentary Pharmacology & Therapeutics	2020	124
Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn’s Disease and Ulcerative Colitis Emilio J. Laserna‐Mendieta, Adam G. Clooney, Juana Carretero‐Gómez, Journal of Crohn s and Colitis	2017	119
Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice Emilio J. Laserna‐Mendieta, Sergio Casabona, Edoardo Savarino, Clinical Gastroenterology and Hepatology Real-world PracticeEsophagusAllergyGastroenterologyEosinophilic Disorder	2020	102
Piphillin predicts metagenomic composition and dynamics from DADA2-corrected 16S rDNA sequences Nicole Narayan, Thomas Weinmaier, Emilio J. Laserna‐Mendieta, BMC Genomics	2020	84
Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis Pilar Navarro, Emilio J. Laserna‐Mendieta, Danila Guagnozzi, Digestive and Liver Disease EsophagusMedicineGastroenterologyPathologySurgery	2021	60
Biological variation and reference change values of common clinical chemistry and haematologic laboratory analytes in the elderly population Daniel Pineda‐Tenor, Emilio J. Laserna‐Mendieta, Jesús Timón-Zapata, Clinical Chemistry and Laboratory Medicine (CCLM)	2013	56
Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies Emilio J. Laserna‐Mendieta, Jamie A. FitzGerald, Laura Arias‐González, Scientific Reports	2021	44

Page 1